Cdc25 inhibited in vivo and in vitro by checkpoint kinases Cds1 and Chk1
B Furnari1, A Blasina, M N Boddy
1Departments of Molecular Biology and Cell Biology, The Scripps Research Institute, La Jolla, California 92037, USA.
Abstract:
In the fission yeast Schizosaccharomyces pombe, the protein kinase Cds1 is activated by the S-M replication checkpoint that prevents mitosis when DNA is incompletely replicated. Cds1 is proposed to regulate Wee1 and Mik1, two tyrosine kinases that inhibit the mitotic kinase Cdc2. Here, we present evidence from in vivo and in vitro studies, which indicates that Cds1 also inhibits Cdc25, the phosphatase that activates Cdc2. In an in vivo assay that measures the rate at which Cdc25 catalyzes mitosis, Cds1 contributed to a mitotic delay imposed by the S-M replication checkpoint. Cds1 also inhibited Cdc25-dependent activation of Cdc2 in vitro. Chk1, a protein kinase that is required for the G2-M damage checkpoint that prevents mitosis while DNA is being repaired, also inhibited Cdc25 in the in vitro assay. In vitro, Cds1 and Chk1 phosphorylated Cdc25 predominantly on serine-99. The Cdc25 alanine-99 mutation partially impaired the S-M replication and G2-M damage checkpoints in vivo. Thus, Cds1 and Chk1 seem to act in different checkpoint responses to regulate Cdc25 by similar mechanisms.
Insights
The protein kinase Cds1 and Chk1 inhibit Cdc25, a key regulator of mitosis, by phosphorylating it. This mechanism is crucial for the S-M replication and G2-M damage checkpoints in fission yeast.
Area of Science:
- Cell cycle regulation
- DNA replication checkpoints
- Protein kinase signaling
Background:
- Cds1 (protein kinase) is activated by the S-M replication checkpoint in fission yeast.
- Cds1 is known to regulate Wee1 and Mik1, which inhibit the mitotic kinase Cdc2.
- The precise mechanisms by which Cds1 enforces the S-M checkpoint are still being elucidated.
Purpose of the Study:
- To investigate the role of Cds1 in regulating Cdc25, the phosphatase that activates Cdc2.
- To determine if Chk1 also regulates Cdc25.
- To elucidate the mechanism of Cds1 and Chk1 action on Cdc25.
Main Methods:
- In vivo assays measuring Cdc25-catalyzed mitosis rates.
- In vitro assays examining Cds1 and Chk1 inhibition of Cdc25.
- Site-directed mutagenesis (Cdc25 alanine-99 mutation).
Main Results:
- Cds1 inhibits Cdc25 activity, contributing to mitotic delay during the S-M replication checkpoint.
- Chk1 also inhibits Cdc25 activity in vitro.
- Cds1 and Chk1 phosphorylate Cdc25 on serine-99 in vitro.
- Mutation of serine-99 in Cdc25 partially impairs both S-M replication and G2-M damage checkpoints in vivo.
Conclusions:
- Cds1 and Chk1 regulate Cdc25 through similar phosphorylation mechanisms.
- These kinases play a role in distinct checkpoint pathways (S-M replication and G2-M damage).
- Phosphorylation of Cdc25 at serine-99 is a key event in checkpoint control.
Related Concept Videos
Positive Regulator Molecules
DNA Damage can Stall the Cell Cycle
Positive Regulator Molecules
Inhibition of Cdk Activity
DNA Damage Can Stall the Cell Cycle
Inhibition of CDK Activity


